Columbia Partners Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$1.76M Hold
29,484
0.68% 43
2018
Q3
$1.9M Sell
29,484
-11,469
-28% -$640K 0.49% 56
2018
Q2
$1.84M Sell
40,953
-11,009
-21% -$439K 0.53% 62
2018
Q1
$1.61M Sell
51,962
-19,089
-27% -$628K 0.21% 137
2017
Q4
$2.12M Buy
71,051
+16,453
+30% +$476K 0.28% 111
2017
Q3
$1.8M Buy
+54,598
New +$1.89M 0.24% 129
2015
Q1
Sell
-1,013,630
Closed -$10.2M 379
2014
Q4
$10.2M Sell
1,013,630
-357,221
-26% -$3.06M 0.53% 69
2014
Q3
$9.2M Sell
1,370,851
-1,092,835
-44% -$7.66M 0.47% 81
2014
Q2
$17.7M Sell
2,463,686
-406,073
-14% -$3.23M 0.82% 23
2014
Q1
$29M Buy
2,869,759
+501,599
+21% +$4.62M 1.26% 10
2013
Q4
$18.8M Buy
2,368,160
+487,996
+26% +$4.55M 0.81% 29
2013
Q3
$18.6M Buy
1,880,164
+1,601,602
+575% +$12.6M 0.83% 25
2013
Q2
$1.64M Buy
+278,562
New +$937K 0.08% 225

Other funds holding BEAT

Columbia Partners Investment Management's BEAT Position: Q4 2018 in Review

Columbia Partners Investment Management held its BioTelemetry, Inc. (BEAT) position steady in Q4 2018 at 29,484 shares worth $1.76M. The position accounts for 0.68% of the portfolio, ranked #43.

Columbia Partners Investment Management first reported a position in BEAT in Q2 2013 and has held it in 13 quarters since. The position peaked at $29M in Q1 2014. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • Columbia Partners Investment Management held 29,484 shares of BioTelemetry, Inc. worth $1.76M as of Q4 2018.
  • Columbia Partners Investment Management left its BioTelemetry, Inc. share count unchanged in Q4 2018.
  • BioTelemetry, Inc. made up 0.68% of Columbia Partners Investment Management's portfolio in Q4 2018, its #43 holding.
  • Columbia Partners Investment Management first reported a position in BioTelemetry, Inc. in Q2 2013 and has held it in 13 quarters since.
  • Columbia Partners Investment Management's BioTelemetry, Inc. position peaked at $29M in Q1 2014.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on Columbia Partners Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.